Mangalam Drugs and Organics Ltd share price logo

Mangalam Drugs Share Price

NSE: MANGALAM

BSE: 532637

Small Cap

Healthcare Sector

₹31.66

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Mangalam Drugs Stock Performance

as on February 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹31.00
    ₹32.69
    downward going graph

    2.08%

    Downside

    3.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹22.80
    ₹109.80
    downward going graph

    27.98%

    Downside

    246.81%

    Upside

    downward going graph

Mangalam Drugs share price movements today

Previous Close
₹31.66
Open
₹31.50
Volume
48.98K
Upper Circuit
₹33.24
Lower Circuit
₹30.08
Day's Low - High
₹31.00 - ₹32.69
52 Week Low - High
₹22.80 - ₹109.80

Mangalam Drugs Historical Returns

1 Month Return
-38.89 %
3 Month Return
-34.49 %
1 Year Return
-69.44 %
3 Year Return
-71.64 %
5 Year Return
-71.1 %

Mangalam Drugs Fundamentals

as on February 20, 2026 at 4:01 pm IST

Market Cap

₹50.11 Cr

Return on Equity (ROE)

4.76

PE Ratio (TTM)

-1.62

Return on capital employed (ROCE)

7.94

Industry PE ratio

41.62

Beta (LTM)

1.08

P/B Ratio

0.79

Dividend Yield

0

PEG Ratio

0.06

Quarterly Earnings Growth YOY

-862.79

EPS (TTM)

4.25

Sector

Pharmaceuticals

Book Value

89.65

Technical Analysis

Bearish

View Technical Analysis

Mangalam Drugs Stock Valuation

as on February 20, 2026 at 4:01 pm IST

Mangalam Drugs in the last 5 years

  • Overview

  • Trends

Lowest (-14.99x)

July 23, 2025

Today (-1.62x)

February 19, 2026

Industry (41.62x)

February 19, 2026

Highest (21.50x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.62x

Mangalam Drugs and Organics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mangalam Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mangalam Drugs and Organics Ltd image
Mangalam Drugs and Organics Ltd
NA50.11-14.22%0.706318
Vilin Bio Med Ltd image
Vilin Bio Med Ltd
NA49.384.84%0.00114
Sanjivani Paranteral Ltd image
Sanjivani Paranteral Ltd
NA239.97331.98%0.61870
Viyash Scientific Ltd image
Viyash Scientific Ltd
NA9,418.72-2.12%0.72321,551
Gujarat Terce Laboratories Ltd image
Gujarat Terce Laboratories Ltd
NA30.5494.17%0.00-150
See all

Mangalam Drugs Stock’s Investor Sentiment and Interest

Search interest for Mangalam Drugs and Organics Ltd Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

Mangalam Drugs and Organics Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
97.05
101.94
76.49
79.75
88.55
72.78
57.21
49.26
58.38
Other Income
-
0.05
0.02
0.14
0.14
0.21
-
0.03
0.11
Total Income
97.34
102.28
76.56
80.08
88.85
73.25
57.35
49.57
58.6
Expenses
90.36
90.54
68.35
71.24
79.94
62.88
61.83
52.38
59.92
Operating Profit
6.69
11.4
8.14
8.51
8.61
9.9
-4.62
-3.12
-1.54
Operating Profit Margin %
6.89%
11.18%
10.64%
10.67%
9.72%
13.6%
-8.08%
-6.33%
-2.64%
Profit Before Interest, Tax and Depreciation
6.98
11.74
8.21
8.84
8.91
10.37
-4.48
-2.81
-1.32
Interest
3.31
3.95
3.75
3.67
3.49
4.03
4.04
5.03
4.05
Depreciation
3.63
3.86
3.88
3.97
4.05
4.7
4.48
4.63
4.46
Profit Before Tax
0.04
3.93
0.58
1.2
1.37
1.64
-13
-12.47
-9.83
Tax Paid
-0.46
0.4
-2.1
-1.49
0.08
1.57
0.8
-5.12
-
Profit After Tax
0.5
3.53
2.68
2.69
1.29
0.06
-13.8
-7.35
-9.84
Total Net profit including share of profit / Loss from associate company
0.5
3.53
2.68
2.69
1.29
0.06
-13.8
-7.35
-9.84
EPS
0.31
2.23
1.7
1.7
0.81
0.04
-8.72
-4.64
-6.21
Actual EPS
0.31
2.23
1.7
1.7
0.81
0.04
-8.72
-4.64
-6.21
Adjusted EPS
0.31
2.23
1.7
1.7
0.81
0.04
-8.72
-4.64
-6.21
Diluted EPS
0.31
2.23
1.7
1.7
0.81
0.04
-8.72
-4.64
-6.21

Mangalam Drugs and Organics Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2024
Mar 2025
Sales
367.35
317.58
Other Income
0.1
0.5
Total Income
368.69
318.73
Expenses
351.2
282.41
Operating Profit
16.15
35.17
Operating Profit Margin %
4.4%
11.07%
Profit Before Interest, Tax and Depreciation
17.49
36.33
Interest
13.92
14.93
Depreciation
14.65
16.61
Profit Before Tax
-11.08
4.79
Tax Paid
-2
-1.94
Profit After Tax
-9.07
6.72
Total Net profit including share of profit / Loss from associate company
-9.07
6.72
EPS
-5.73
4.25
Actual EPS
-5.73
4.25
Adjusted EPS
-5.73
4.25
Diluted EPS
-5.73
4.25

Mangalam Drugs and Organics Ltd Cash Flow

Figures in Rupees Crores

Mar 2024
Mar 2025
Net Cash from Operating Activities
3.91
42.59
Cash Flow from Investing Activities
-11.82
-19.47
Cash Flow from Financing Activities
5.23
-21.71
Net Cash Flow
-2.69
1.41

Mangalam Drugs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
50.32%
50.32%
50.32%
50.32%
50.32%
50.32%
50.3%
50.3%
50.3%
50.3%
50.3%
35.64%
FII
0%
0%
0%
0.1%
0.26%
0.21%
0.11%
0.11%
0.47%
0.53%
0.11%
0.13%
Public
49.58%
49.58%
49.58%
49.58%
49.42%
49.47%
49.58%
49.58%
49.23%
49.16%
49.58%
64.22%
Total Outstanding Shares
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
1,58,28,248
Total Shareholders
17,943
17,890
17,978
18,610
19,173
19,312
19,508
19,679
19,697
19,728
19,881
21,227

Mangalam Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Mangalam Drugs.

  • Mangalam Drugs and Organics Ltd Earnings Results

    Mangalam Drugs and Organics Ltd’s net profit fell -862.79% since last year same period to ₹-9.84Cr in the Q3 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -33.88% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Mangalam Drugs and Organics Ltd Dividends December,2017

    In the quarter ending September 2017, Mangalam Drugs and Organics Ltd has declared dividend of ₹0.50 per share on 12 Dec 2017 - translating a dividend yield of 1.58%.

    Read More about Dividends

Insights on Mangalam Drugs and Organics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.11% to 0.13% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 49.58% to 64.22% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 36.5% return, outperforming this stock by 106.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 185.2% return, outperforming this stock by 256.8%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 50.30% to 35.64% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, MANGALAM stock has moved down by -38.9%

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd is an India-based manufacturer of organic and inorganic chemicals, active pharma ingredients, API perfumery, disperse dye intermediates, bulk drugs, and bulk drug intermediates. Established in April 1972, the company has operations at Vapi in Gujarat and Sangamner in Maharashtra, and a Research and Development base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, dyes and intermediaries, Nimesulide, Amodiaquine Hydrochloride and Amodiaquine. The bulk drug production capacity of the Company was increased from 350 MTPA to 1260 MTPA between 2003-04 and 2009-10. In addition to this, the company developed and introduced two new bulk drugs: Bisoprolol Fumarate and Pantaprazole Sodium. Furthermore, an Intellectual Property Rights (IPR) and Regulatory Affairs Cell have been created for proper management and expansion of their products.

Revenue: ₹58.38Cr as on December 2025 (Q3 FY26)
Net Profit: ₹-9.84Cr as on December 2025 (Q3 FY26)
Listing date: 23 May, 2005
Chairperson Name: Govardhan M Dhoot
OrganisationMangalam Drugs and Organics Ltd
IndustryPharmaceuticals
CEOGovardhan M Dhoot
E-voting on sharesClick here to vote

FAQs

What is Mangalam Drugs share price today?

Mangalam Drugs share price today stands at ₹31.66 as on at the close of the market. Mangalam Drugs share today touched a day high of ₹32.69 and a low of ₹31.

What is the 52 week high and 52 week low range for Mangalam Drugs share?

Mangalam Drugs touched a 52 week high of ₹109.8 and a 52 week low of ₹22.8. Mangalam Drugs share price today i.e. is closed at ₹31.66, which is -71.17% down from its 52 week high and 38.86% up from its 52 week low.

What is Mangalam Drugs's market capitalisation today?

Mangalam Drugs market capitalisation is ₹50.11 Cr as on .

How to buy Mangalam Drugs shares?

To buy Mangalam Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANGALAM or Mangalam Drugs and Organics Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mangalam Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mangalam Drugs trading volume today?

Mangalam Drugs trading volume is 48.98K as on . This means that 48.98K shares of Mangalam Drugs were bought and sold on the stock market during today's trading session.